133 related articles for article (PubMed ID: 28528272)
1. Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions.
Lunde NN; Haugen MH; Bodin Larsen KB; Damgaard I; Pettersen SJ; Kasem R; Rut W; Drag M; Poreba M; Johansen HT; Solberg R
Biochimie; 2017 Aug; 139():27-37. PubMed ID: 28528272
[TBL] [Abstract][Full Text] [Related]
2. Intra- and extracellular regulation of activity and processing of legumain by cystatin E/M.
Smith R; Johansen HT; Nilsen H; Haugen MH; Pettersen SJ; Mælandsmo GM; Abrahamson M; Solberg R
Biochimie; 2012 Dec; 94(12):2590-9. PubMed ID: 22902879
[TBL] [Abstract][Full Text] [Related]
3. Autoactivation of prolegumain is accelerated by glycosaminoglycans.
Berven L; Johansen HT; Solberg R; Kolset SO; Samuelsen AB
Biochimie; 2013 Apr; 95(4):772-81. PubMed ID: 23160071
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a novel legumain-cleavable colchicine prodrug with cell-specific toxicity.
Smith RL; Åstrand OA; Nguyen LM; Elvestrand T; Hagelin G; Solberg R; Johansen HT; Rongved P
Bioorg Med Chem; 2014 Jul; 22(13):3309-15. PubMed ID: 24842619
[TBL] [Abstract][Full Text] [Related]
5. Low-level internalization of cystatin E/M affects legumain activity and migration of melanoma cells.
Wallin H; Apelqvist J; Andersson F; Ekström U; Abrahamson M
J Biol Chem; 2017 Sep; 292(35):14413-14424. PubMed ID: 28630039
[TBL] [Abstract][Full Text] [Related]
6. Cystatin E/M suppresses legumain activity and invasion of human melanoma.
Briggs JJ; Haugen MH; Johansen HT; Riker AI; Abrahamson M; Fodstad Ø; Maelandsmo GM; Solberg R
BMC Cancer; 2010 Jan; 10():17. PubMed ID: 20074384
[TBL] [Abstract][Full Text] [Related]
7. Cystatin M/E is a high affinity inhibitor of cathepsin V and cathepsin L by a reactive site that is distinct from the legumain-binding site. A novel clue for the role of cystatin M/E in epidermal cornification.
Cheng T; Hitomi K; van Vlijmen-Willems IM; de Jongh GJ; Yamamoto K; Nishi K; Watts C; Reinheckel T; Schalkwijk J; Zeeuwen PL
J Biol Chem; 2006 Jun; 281(23):15893-9. PubMed ID: 16565075
[TBL] [Abstract][Full Text] [Related]
8. Evidence that unrestricted legumain activity is involved in disturbed epidermal cornification in cystatin M/E deficient mice.
Zeeuwen PL; van Vlijmen-Willems IM; Olthuis D; Johansen HT; Hitomi K; Hara-Nishimura I; Powers JC; James KE; op den Camp HJ; Lemmens R; Schalkwijk J
Hum Mol Genet; 2004 May; 13(10):1069-79. PubMed ID: 15044380
[TBL] [Abstract][Full Text] [Related]
9. Activation of human prolegumain by cleavage at a C-terminal asparagine residue.
Chen JM; Fortunato M; Barrett AJ
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):327-34. PubMed ID: 11085925
[TBL] [Abstract][Full Text] [Related]
10. Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase.
Chen JM; Dando PM; Rawlings ND; Brown MA; Young NE; Stevens RA; Hewitt E; Watts C; Barrett AJ
J Biol Chem; 1997 Mar; 272(12):8090-8. PubMed ID: 9065484
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole inhibits the cysteine protease legumain by binding to the active site.
Bosnjak T; Solberg R; Hemati PD; Jafari A; Kassem M; Johansen HT
Basic Clin Pharmacol Toxicol; 2019 Aug; 125(2):89-99. PubMed ID: 30916878
[TBL] [Abstract][Full Text] [Related]
12. Colocalization of cystatin M/E and cathepsin V in lamellar granules and corneodesmosomes suggests a functional role in epidermal differentiation.
Zeeuwen PL; Ishida-Yamamoto A; van Vlijmen-Willems IM; Cheng T; Bergers M; Iizuka H; Schalkwijk J
J Invest Dermatol; 2007 Jan; 127(1):120-8. PubMed ID: 16874311
[TBL] [Abstract][Full Text] [Related]
13. The Mammalian Cysteine Protease Legumain in Health and Disease.
Solberg R; Lunde NN; Forbord KM; Okla M; Kassem M; Jafari A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555634
[TBL] [Abstract][Full Text] [Related]
14. Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase.
Chen JM; Fortunato M; Stevens RA; Barrett AJ
Biol Chem; 2001 May; 382(5):777-83. PubMed ID: 11517930
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
[TBL] [Abstract][Full Text] [Related]
16. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
[TBL] [Abstract][Full Text] [Related]
17. Cystatin C properties crucial for uptake and inhibition of intracellular target enzymes.
Wallin H; Abrahamson M; Ekström U
J Biol Chem; 2013 Jun; 288(23):17019-17029. PubMed ID: 23629651
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional analysis of cystatin E reveals enzymologically relevant dimer and amyloid fibril states.
Dall E; Hollerweger JC; Dahms SO; Cui H; Häussermann K; Brandstetter H
J Biol Chem; 2018 Aug; 293(34):13151-13165. PubMed ID: 29967063
[TBL] [Abstract][Full Text] [Related]
19. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain.
Sexton KB; Witte MD; Blum G; Bogyo M
Bioorg Med Chem Lett; 2007 Feb; 17(3):649-53. PubMed ID: 17189693
[TBL] [Abstract][Full Text] [Related]
20. N-linked glycosylation of the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA)-selective glutamate receptor channel alpha 2 subunit is essential for the acquisition of ligand-binding activity.
Kawamoto S; Hattori S; Sakimura K; Mishina M; Okuda K
J Neurochem; 1995 Mar; 64(3):1258-66. PubMed ID: 7532209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
